Synergy Pharmaceuticals announced the initiation of dosing in a Phase 2a clinical trial of SP-304 in patients with chronic constipation (CC). This trial is a randomized, double-blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results